Work

Current utilization of molecular residual disease (MRD) testing in colorectal cancer: Q&A.

Year: 2025

Type: article

Source: PubMed

Authors: Tanios S Bekaii-Saab, Robert E Schoen

Institutions: Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona), University of Pittsburgh

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411977879

FWCI:

Cites:

Cited by:

Related to: 10